Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity

Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity

Purpose. To evaluate functional and anatomic effects of intravitreal bevacizumab in patients with neovascular AMD and initial low visual acuity. Methods. Retrospective case series of 38 eyes with neovascular AMD and initial visual acuity of 20/200 or less, treated with intravitreal bevacizumab injec...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leila El Matri, Rym Bouraoui, Ahmed Chebil, Fedra Kort, Mejda Bouladi, Rym Limaiem, Hana Landoulsi
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2012/861384
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pengaruh Bevacizumab Intravitreal terhadap Best Corrected Visual Acuity dan Central Macular Thickness pada Diabetic Macular Edema
by: Arini Ghaisa Atsari, et al.
Published: (2020-01-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
by: Wenjuan Luo, et al.
Published: (2018-01-01)

Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
by: Hossein Ashraf, et al.
Published: (2025-06-01)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
by: Tatsuya Yunoki, et al.
Published: (2013-01-01)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
by: O’Sam Shibeeb, et al.
Published: (2014-01-01)

Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis
by: Alessandro Randazzo, et al.
Published: (2021-01-01)

Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study
by: Ayman G. Elnahry, et al.
Published: (2020-01-01)

Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
by: LakshmiPriya Rangaraju, et al.
Published: (2018-01-01)

Microperimetric Biofeedback Training Improved Visual Acuity after Successful Macular Hole Surgery
by: Tomoko Ueda-Consolvo, et al.
Published: (2015-01-01)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
by: Ying Zhang, et al.
Published: (2022-01-01)

Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence
by: Bogumiła Sędziak-Marcinek, et al.
Published: (2021-01-01)

Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
by: Manish Nagpal, et al.
Published: (2011-01-01)

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children
by: Chu Luan Nguyen, et al.
Published: (2018-01-01)

Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012-01-01)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
by: Belghmaidi Sarah, et al.
Published: (2016-01-01)

Long-Term Outcomes of Rheohaemapheresis in the Treatment of Dry Form of Age-Related Macular Degeneration
by: Jan Studnička, et al.
Published: (2013-01-01)

Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study
by: Lucy J. Kessler, et al.
Published: (2021-01-01)

Age-Related Macular Degeneration: Insights into Inflammatory Genes
by: Raffaella Cascella, et al.
Published: (2014-01-01)

Future Therapies of Wet Age-Related Macular Degeneration
by: Makoto Ishikawa, et al.
Published: (2015-01-01)

Ocular Surface Temperature in Age-Related Macular Degeneration
by: Andrea Sodi, et al.
Published: (2014-01-01)

Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
by: Oliver Zeitz, et al.
Published: (2022-06-01)

Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
by: Yasmin Ali Said, et al.
Published: (2021-01-01)

Saffron therapy for the ongoing treatment of age-related macular degeneration
by: Peter J McCluskey, et al.
Published: (2024-07-01)

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration
by: Chi-Chao Chan, et al.
Published: (2008-01-01)

Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration
by: Sara Toulouie, et al.
Published: (2022-01-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Association Of Conjunctival Vitreous Reflux With Intraocular Pressure Spikes After Intravitreal Bevacizumab Injection
by: Kanwal Zareen Abbasi, et al.
Published: (2024-04-01)

Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome
by: Joseph Pikkel, et al.
Published: (2013-01-01)

Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis
by: Eva Rencová, et al.
Published: (2015-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration
by: Agnieszka Nowosielska
Published: (2024-12-01)

Critical Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration
by: Annie M. Wu, et al.
Published: (2015-01-01)

Identification of Key Genes and Pathways Associated with Age-Related Macular Degeneration
by: Junyu Zhang, et al.
Published: (2020-01-01)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
by: Jiangyuan Gao, et al.
Published: (2015-01-01)

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
by: Amber khalid, et al.
Published: (2025-01-01)

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration
by: Lucas Stürzbecher, et al.
Published: (2025-02-01)